We understand that it can be challenging to gain clarity and perspective on breaking Parkinson's news. Q&As in this section are conducted with leading experts in the Parkinson's disease research field to quickly provide an informed, impartial opinion on new findings -- and to get to the bottom of what they might mean for researchers and people living with PD today.
AARP The Magazine, "Michael J. Fox Is Back With a New Show and Feelin' Alright After 20+ Years With Parkinson's"
April 22, 2013
Michael graces the April cover of AARP The Magazine and talks about family, his new show, and his optimistic outlook on life with Parkinson's. The Foundation's Debi Brooks and Todd Sherer are also quoted in the article.Read More
April 19, 2013
Ceregene today announced disappointing results from its second Phase 2 trial of CERE-120, an experimental gene therapy treatment for Parkinson's disease (PD). CERE-120 was designed to deliver neurturin, a specialized protein known as a trophic factor, into the brain. The hope was that it might heal diseased brain cells, helping to slow the progression of the disease, a therapeutic effect suggested in pre-clinical studies of neurturin.
CERE-120 did not reach its primary endpoint in this study, u...Read More
March 30, 2013
The Lancet recommends that the NIH Parkinson's Disease Biomarkers Program should aim to coordinate data collection methods with and validate findings from Foundation-led studies the Parkinson's Progression Markers Initiative and BioFIND.Read More